General
Lupin Neurosciences is committed to working with Healthcare Professionals to develop science-based solutions that stretch beyond access to lifechanging treatment options to optimize patient care in underserved neurological diseases.
ICNMD: 9th International Congress on Neuromuscular Diseases, Florence, Italy, 7-11 July
9th International Congress on Neuromuscular Diseases, Florence, Italy, 7-11 July
Non-dystrophic myotonia
236
Design of ACHILLES Phase 3 randomised study: mexiletine PR vs. mexiletine IR in non-dystrophic myotonia
Kristl G. Claeys, Remiche Gauthier, Dipa Jayaseelan, Guido Primiano, Savine Vicart, Rocío-Nur Villar-Quiles, Jana Zschüntzsch, Nikki Adetoro, Russell Brierley, Alla Zozulya-Weidenfeller
Abstract: Abstract
Poster: Poster